Data from a comparative study found liraglutide and dulaglutide presented similar effectiveness as semaglutide in the ...

A phase 3 study shows tafasitamab combined with lenalidomide and R-CHOP significantly improves outcomes for untreated DLBCL patients.

Patients with juvenile fibromyalgia have sustained improvements in disability through psychologic and exercise-based interventions.

Bristol-Myers Squibb Company ($BMY) announced an update on their ongoing clinical study. Study Overview Bristol-Myers Squibb ...

Company expects topline data from the study in 2027WESTLAKE VILLAGE, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Angitia Biopharmaceuticals, a ...

Dr. Raza Bokhari, Executive Chairman & CEO of Medicus will deliver a company presentation as Medicus enters 2026 with multiple Phase 2 Catalysts across clinical, regulatory, and pipeline expansion ...

Neumora Therapeutics (NMRA) announced results from its Phase 1b signal-seeking study of NMRA-511 in people with Alzheimer’s disease agitation.

New research shows that replacing high-carbohydrate snacks with tree nuts reduced cravings for sweets and fast food while ...

The approval marks the first new stroke treatment authorized in nearly 27 years, offering an additional option for managing acute ischemic stroke in Canada. MISSISSAUGA, ON, Dec. 17, 2025 /CNW/ - ...

Unexpected results from a controlled dietary study raise new questions about how sweetness itself affects human health. The data hint that our assumptions about sweet taste may need updating. Credit: ...

Adding a 12-week structured physical exercise program to standard care was associated with alleviated symptoms and improved quality of life in adults with attention ...